<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
    <front>
        <journal-meta>
            <journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
            <journal-title>Molecular Brain</journal-title>
            <issn pub-type="epub">1756-6606</issn>
            <publisher>
                <publisher-name>BioMed Central</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="pmc">2687442</article-id>
            <article-id pub-id-type="publisher-id">1756-6606-2-10</article-id>
            <article-id pub-id-type="pmid">19419578</article-id>
            <article-id pub-id-type="doi">10.1186/1756-6606-2-10</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Regulation of dopamine transporter activity by carboxypeptidase E</article-title>
            </title-group>
            <contrib-group>
                <contrib id="A1" contrib-type="author">
                    <name>
                        <surname>Zhang</surname>
                        <given-names>Heping</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <email>peacezhp@yahoo.com.cn</email>
                </contrib>
                <contrib id="A2" contrib-type="author">
                    <name>
                        <surname>Li</surname>
                        <given-names>Shupeng</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <email>lishupeng76@gmail.com</email>
                </contrib>
                <contrib id="A3" contrib-type="author">
                    <name>
                        <surname>Wang</surname>
                        <given-names>Min</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <email>Min_Wang@camh.net</email>
                </contrib>
                <contrib id="A4" contrib-type="author">
                    <name>
                        <surname>Vukusic</surname>
                        <given-names>Brian</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <email>brianvukusic@gmail.com</email>
                </contrib>
                <contrib id="A5" contrib-type="author">
                    <name>
                        <surname>Pristupa</surname>
                        <given-names>Zdenek B</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <email>z.pristupa@utoronto.ca</email>
                </contrib>
                <contrib id="A6" corresp="yes" contrib-type="author">
                    <name>
                        <surname>Liu</surname>
                        <given-names>Fang</given-names>
                    </name>
                    <xref ref-type="aff" rid="I1">1</xref>
                    <xref ref-type="aff" rid="I2">2</xref>
                    <email>fang_liu@camh.net</email>
                </contrib>
            </contrib-group>
            <aff id="I1"><label>1</label>Department of Neuroscience, Centre for Addiction and Mental Health, Toronto,
                Ontario, Canada
            </aff>
            <aff id="I2"><label>2</label>Departments of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8,
                Canada
            </aff>
            <pub-date pub-type="collection">
                <year>2009</year>
            </pub-date>
            <pub-date pub-type="epub">
                <day>6</day>
                <month>5</month>
                <year>2009</year>
            </pub-date>
            <volume>2</volume>
            <fpage>10</fpage>
            <lpage>10</lpage>
            <ext-link ext-link-type="uri" xlink:href="http://www.molecularbrain.com/content/2/1/10"/>
            <history>
                <date date-type="received">
                    <day>9</day>
                    <month>5</month>
                    <year>2008</year>
                </date>
                <date date-type="accepted">
                    <day>6</day>
                    <month>5</month>
                    <year>2009</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright &#x000a9; 2009 Zhang et al; licensee BioMed Central Ltd.
                </copyright-statement>
                <copyright-year>2009</copyright-year>
                <copyright-holder>Zhang et al; licensee BioMed Central Ltd.</copyright-holder>
                <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
                    <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution
                        License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>
                        ), which permits unrestricted use, distribution, and reproduction in any medium, provided the
                        original work is properly cited.
                    </p>
                    <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
          Zhang
          Heping

          peacezhp@yahoo.com.cn
       </dc:author><dc:title>
       Regulation of dopamine transporter activity by carboxypeptidase E
    </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Molecular Brain 2(1): 10-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1756-6606(2009)2:1&#x0003c;10&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1756-6606</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
                </license>
            </permissions>
            <abstract>
                <sec>
                    <title>Background</title>
                    <p>The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by
                        rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl
                        terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function
                        and trafficking.
                    </p>
                </sec>
                <sec>
                    <title>Results</title>
                    <p>Here, we have identified that carboxypeptidase E (CPE), a prohormone processing exopeptidase and
                        sorting receptor for the regulated secretory pathway, interacts with the DAT-CT and affects DAT
                        function. Mammalian cell lines coexpressing CPE and DAT exhibited increased DAT-mediated
                        dopamine uptake activity compared to cells expressing DAT alone. Moreover, coexpression of an
                        interfering DAT-CT minigene inhibited the effects of CPE on DAT. Functional changes caused by
                        CPE could be attributed to enhanced DAT expression and subsequent increase in DAT cell surface
                        localization, due to decreased DAT degradation. In addition, CPE association could reduce the
                        phosphorylation state of DAT on serine residues, potentially leading to reduced internalization,
                        thus stabilizing plasmalemmal DAT localization.
                    </p>
                </sec>
                <sec>
                    <title>Conclusion</title>
                    <p>Taken together, our results reveal a novel role for CPE in the regulation of DAT trafficking and
                        DAT-mediated DA uptake, which may provide a novel target in the treatment of dopamine-governed
                        diseases such as drug addiction and obesity.
                    </p>
                </sec>
            </abstract>
        </article-meta>
    </front>
    <body>
        <sec>
            <title>Background</title>
            <p>The dopamine transporter (DAT) is a presynaptic plasma protein found on dopaminergic nerve terminals that
                terminates dopamine signaling by rapidly sequestering dopamine released into the synaptic cleft [<xref
                        ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. DAT belongs to a
                family of Na+/Cl- dependent transporters with several other neurotransmitter transporters, including
                norepinephrine, serotonin, GABA, and glycine transporters [<xref ref-type="bibr" rid="B2">2</xref>-<xref
                        ref-type="bibr" rid="B4">4</xref>]. Dopamine (DA), an essential neurotransmitter for normal CNS
                functions including motor activity, cognition and reward [<xref ref-type="bibr" rid="B5">5</xref>,<xref
                        ref-type="bibr" rid="B6">6</xref>], which is involved in numerous neurological disorders
                including Parkinson's disease, drug addiction and schizophrenia, is primarily cleared from the synapse [
                <xref ref-type="bibr" rid="B7">7</xref>]. Moreover, the DAT has garnered attention because it is the
                principle target of widely abused psychostimulants, such as cocaine and amphetamine [<xref
                        ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>].
            </p>
            <p>Morphological studies reveal that functional DATs are localized on the plasma membrane of axons,
                pre-synaptic axon terminals, and dendrites of dopaminergic neurons, with the highest expression in the
                axonal processes in striatum and dendrites in ventral tegmental area [<xref ref-type="bibr" rid="B8">
                    8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Specifically, immunoelectron microscopy studies
                find that DAT is located peri-synaptically, indicating that transmitter released at the synapse diffuses
                out of the cleft to be transported into the terminal [<xref ref-type="bibr" rid="B9">9</xref>,<xref
                        ref-type="bibr" rid="B11">11</xref>]. Thus, specific targeting and presentation of DAT in
                neurons require efficient recycling of transporters after internalization or efficient export of newly
                synthesized transporters from the endoplasmic reticulum (ER), sorting to transport carriers in the Golgi
                complex and delivery/retention of transporters at the presynaptic functional sites. The expression,
                trafficking and function of DAT are regulated by several factors including DAT substrates, inhibitors,
                and a variety of signaling cascades including protein kinases and phosphatases [<xref ref-type="bibr"
                                                                                                      rid="B12">
                    12</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. Moreover, structure-function analysis reveals
                several important amino acid residues or structural motifs critical for DAT function. The carboxyl
                terminus (CT) of human DAT has been demonstrated to be important for cell surface expression and proper
                function of DAT [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref
                        ref-type="bibr" rid="B16">16</xref>]. Recent studies using yeast two-hybrid approaches have
                successfully identified several proteins that interact with the DAT carboxyl terminus and influence DAT
                trafficking [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. The
                PDZ domain-containing protein PICK1, which binds to a type II PDZ binding site localized at the DAT
                distal carboxyl termini, increases the efficiency of ER-to-plasma membrane trafficking of the
                transporter [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B16">16</xref>].
                Conversely, Hic-5, a LIM domain containing protein, has also been shown to bind to the DAT-CT and
                inhibit DAT localization to the plasma membrane [<xref ref-type="bibr" rid="B17">17</xref>]. In
                addition, our lab has shown that the DAT CT can also bind to &#x003b1;-synuclein, which stabilizes DAT
                on the surface and could accelerate DA-induced oxidative stress and cell death [<xref ref-type="bibr"
                                                                                                      rid="B18">
                    18</xref>].
            </p>
            <p>The increasing reports of proteins that interact with DAT [<xref ref-type="bibr" rid="B7">7</xref>,<xref
                    ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B26">26</xref>] and their roles in
                the modulation of physiological and pathological DAT functions stress the importance to understand the
                molecular mechanisms of how these interaction proteins affect DAT metabolic cycle and trafficking. Here,
                in an effort to search for candidate proteins capable of interacting with DAT and affecting DAT
                trafficking, we identified the protein carboxypeptidase E (CPE). Biochemical, immunological, and
                functional approaches were employed to examine assembly and trafficking properties of DAT with CPE.
            </p>
        </sec>
        <sec sec-type="methods">
            <title>Methods</title>
            <sec>
                <title>Yeast two-hybrid screening and &#x003b2;-galactosidase assays</title>
                <p>PCR was used to generate CPE-activating domain (AD) fusion constructs in either pACT2 or pGADT7 and
                    binding domain(BD) fusion constructs with the DAT intracellular amino-terminal (NT: Met1-Lys66),
                    carboxyl-terminal (CT1: Leu583-Val620), and carboxyl-terminal fragments (CT2: Glu598-Val620; CT3:
                    Leu583-Pro597) in pAS2 or pGBKT7. Appropriate pairs of AD and BD constructs were cotransformed into
                    the yeast strain Y187 grown at 30&#x000b0;C for 3 days on Leu-/Trp- medium lacking leucine and
                    tryptophan, followed by assay of lacZ reporter activation, present downstream of a GAL4 binding
                    sequence in Y187, as described by the manufacturer (Clontech). All control transformations were
                    negative for &#x003b2;-galactosidase activity except for BD/p53 with AD/T antigen, used as a
                    positive control. All constructs were sequenced to determine appropriate splice fusion and absence
                    of spurious PCR-generated mutations.
                </p>
            </sec>
            <sec>
                <title>Coimmunoprecipitation, affinity purification (pull-down), and Western blotting</title>
                <p>Coimmunoprecipitation, affinity pull-down, and Western blot analyses were performed as previously
                    described [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. Rat
                    brain striatum (100 mg) or transfected COS-7 cells (~2 &#x000d7; 107) were homogenized in buffer
                    containing (in mM) 50 Tris-Cl, pH 7.6, 150 NaCl, 2 EDTA, 1 PMSF plus 1% Igepal CA-630, 0.5 to ~1%
                    sodium deoxycholate, 1% Triton X-100, and protease inhibitor mixture (Sigma); after being
                    centrifuged at 10,000 &#x000d7; g at 4&#x000b0;C for 20 min, the supernatant was extracted and
                    protein concentrations were measured (Pierce, Rockford, IL). For coimmunoprecipitation experiments,
                    solubilized striatum/cell extracts (500 to 700 &#x003bc;g of protein) were incubated in the presence
                    of primary antibodies anti-CPE (Chemicon, B.D Transduction Laboratories&#x02122;), anti-DAT (Santa
                    Cruz Biotechnology, Santa Cruz, CA), or rabbit IgG (1 to 2 &#x003bc;g) for 4 hr at 4&#x000b0;C,
                    followed by the addition of 20 &#x003bc;l of protein A/G agarose (Santa Cruz Biotechnology, Santa
                    Cruz, CA) for 12 hr at 4&#x000b0;C. Pellets were washed four times in the buffer described above,
                    boiled for 5 min in SDS sample buffer, and subjected to SDS-PAGE. In each experiment 20 to 50
                    &#x003bc;g of tissue-extracted protein was used as control. For affinity purification experiments
                    the solubilized striatum extracts (50&#x02013;100 &#x003bc;g of protein) were incubated with
                    glutathione-Sepharose beads (Pharmacia, Dorval, Qu&#x000e9;bec, Canada) bound to the indicated
                    GST-fusion proteins (50 to 100 &#x003bc;g) at 4&#x000b0;C for 12 hr. Beads were washed three times
                    with 600 &#x003bc;l of PBS containing 0.1&#x02013;0.5% Triton X-100 before the bound proteins were
                    eluted with glutathione elution buffer. Elutes were incubated in sample buffer and subjected to
                    SDS-PAGE for Western blot analysis. Blots were blocked with 5% nonfat dried milk dissolved in TBST
                    buffer (10 mM Tris, 150 mM NaCl, and 0.1% Tween-20) for 1 hr at room temperature, washed three times
                    with TBST buffer, and then incubated with the appropriate primary antibody (anti-DAT or anti-CPE,
                    diluted in 1% milk in TBST) overnight at 4&#x000b0;C and washed again with TBST buffer three times;
                    the membrane was incubated with horseradish peroxidase-conjugated secondary antibody (diluted in 1%
                    milk in TBST; Sigma) for 1.5 hr at room temperature. The proteins were visualized with enhanced
                    chemiluminescence reagents as described (Amersham Biosciences).
                </p>
            </sec>
            <sec>
                <title>In vitro binding assay</title>
                <p>A probe was made with CPE subcloned into mammalian expression vector pCDNA3 using TNT<sup>
                    &#x000ae; </sup>T7 Quick Coupled Transcription/Translation System (Promega, Madison, WI) and [<sup>
                    35</sup>S] methionine (PerkinElmer, Waltham, MA). Glutathione beads carrying 20 &#x003bc;g
                    GST-DAT-NT, GST-DAT-CT or GST alone were incubated at room temperature for 1 hour with [<sup>
                        35</sup>S] methionine-labeled CPE probe, respectively. The beads were then washed six times with
                    PBS containing 0.1&#x02013;0.5% (V/V) Triton X-100 and eluted with 10 mM glutathione elution buffer.
                    Eluates were separated by SDS-PAGE and visualized by autoradiography using BioMax (Kodak) film.
                </p>
            </sec>
            <sec>
                <title>[<sup>3</sup>H] Dopamine uptake analysis and [<sup>3</sup>H] WIN binding
                </title>
                <p>We measured dopamine uptake on intact cells as described previously [<xref ref-type="bibr" rid="B18">
                    18</xref>]. Two to 4 days after transfection in 24-well plates (~2 &#x000d7; 10<sup>5</sup>cells
                    seeded per well), medium was removed and wells were rinsed with 0.5 ml of uptake buffer (5 mM Tris,
                    7.5 mM HEPES, 120 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl2, 1.2 mM MgSO4, 1 mM ascorbic acid, 5 mM glucose,
                    pH7.1). Cells were then preincubated in duplicate with the indicated concentrations of dopaminergic
                    agents (10<sup>-13</sup>to 10<sup>-4</sup>M) 5 min before the addition of 0.25 ml of 20 nM [<sup>
                        3</sup>H]dopamine (final concentration) and incubated for 10 min at room temperature in a total
                    volume of 0.5 ml. Nonspecific [<sup>3</sup>H] dopamine (37&#x02013;53 Ci/mmol) uptake was defined in
                    the presence of 10 &#x003bc;M GBR-12909. Wells were rinsed twice with 0.5 ml of uptake buffer; cells
                    were solubilized in 0.5 ml of 1%SDS and collected to measure incorporated radioactivity using a
                    Beckman liquid scintillation counter (LS 6000SC). For [<sup>3</sup>H] WIN binding, the differences
                    from uptake are using [<sup>3</sup>H] WIN (4 nM final concentration) and incubating for 2 to 3 h at
                    4&#x000b0;C before adding 1% SDS.
                </p>
            </sec>
            <sec>
                <title>Cell-ELISA assays</title>
                <p>Cell-ELISA assays (colorimetric assays) were done essentially as previously described [<xref
                        ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. HEK-293 cells
                    were transiently transfected with the indicated cDNA constructs by the Lipofectamine method (6&#x02013;10
                    &#x003bc;g of each indicated cDNA per 7.5 &#x000d7; 10<sup>6</sup>cells), distributed equally to two
                    six-well plates (35 mm/well), and grown for 2&#x02013;4 d. The cotransfected cells were fixed in 2%
                    paraformaldehyde for 10 min in the absence (nonpermeabilized conditions) or the presence
                    (permeabilized conditions) of 1% TritonX-100. Cells were incubated with anti-DAT (Chemicon) for the
                    purpose of labeling the receptors on the cell surface under nonpermeabilized conditions or the
                    entire receptor pool under permeabilized conditions. After incubation with the corresponding
                    horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma), the HRP substrate
                    o-phenylenediamine (OPD; Sigma) was added to produce a color reaction that was stopped with 3 N HCl.
                    The cell surface and total expression of DAT was presented as the colorimetric readings under
                    nonpermeabilized and permeabilized conditions and then normalized to the control groups (transfected
                    with DAT alone) respectively.
                </p>
            </sec>
            <sec>
                <title>Pulse-Chase analysis</title>
                <p>HEK 293 T cells were transiently transfected with DAT or together with CPE, grown to near-confluency
                    over 12 hr, pre-incubated in extracellular solution (7 mM HEPES, 121 mM NaCL, 3 mM NaHCO3, 1 mM
                    Na-pyruvate, 1.8 mM CaCL2, 20 mM glucose, 0.01 mM glycine, 5 mM KCL), for 1 h at 37&#x000b0;C, and
                    labeled in fresh medium containing 0.2 mCi/ml promix [35S] methionine/cysteine (Amersham
                    Biosciences). After incubation for a further 4 h at 37&#x000b0;C, the pulse was terminated by
                    washing cells twice and incubating with MEM (supplemented with 10% FBS) for the indicated times.
                    Immunoprecipitation of DAT was carried out.
                </p>
            </sec>
            <sec>
                <title>Cell culture and confocal imaging</title>
                <p>After tranfection (as above) for 2&#x02013;4 d, HEK-293 cells were used for double-label
                    immunoconfocal microscopy. CPE mouse Abs (Pharmacia) and DAT Rabbit Abs (Santa Cruz) were used as
                    primary antibodies in overnight incubations at 4&#x000b0;C and detected using secondary antibodies
                    (Sigma) conjugated to FITC or Cy3 fluorophores. Control cells in which no primary Ab was included
                    did not reveal any immunoreactive staining.
                </p>
            </sec>
            <sec>
                <title>GST fusion proteins and mini-gene</title>
                <p>DAT CT cDNA-encoding fragment was amplified by PCR from full-length cDNA clones [<xref
                        ref-type="bibr" rid="B18">18</xref>]. DAT CT and DAT NT GST-fusion proteins were prepared from
                    bacterial lysates as described by the manufacturer (Amersham Biosciences). To confirm appropriate
                    splice fusion and the absence of spurious PCR-generated nucleotide errors, we resequenced all
                    constructs.
                </p>
            </sec>
            <sec>
                <title>Acute Rat Striatum slices</title>
                <p>Acute hippocampal slices (350 &#x003bc;m) were prepared from Sprague-Dawley rats using a McIlwain
                    tissue chopper (Mickle Laboratory Engineering, Gomshall, UK). Under deep anesthesia, brains were
                    rapidly removed and striatum was dissected out and leave for 5 mins in ice-cold artificial
                    cerebrospinal fluid (ACSF) containing (mM) NaCl, 126; KCl, 2.5; MgCl2, 1; CaCl2, 1; KH2PO4, 1.25;
                    NaHCO3, 26; and glucose, 20 that was bubbled continuously with carbogen (95%O2/5%CO2) to adjust the
                    pH to 7.4. Freshly cut slices were placed in an incubating chamber with carbogenated ACSF and
                    recovered from stress at 37&#x000b0;C for 1 hr. Slices were then treated with/without PMA for 30
                    mins and harvested for Co-immunoprecipitation and Western blotting analysis.
                </p>
            </sec>
        </sec>
        <sec>
            <title>Results</title>
            <sec>
                <title>DAT CT directly interacts with CPE</title>
                <p>To search for DAT-interacting proteins, we employed the entire DAT-CT as bait to screen a human
                    substantia nigra library using the yeast two-hybrid system (Fig<xref ref-type="fig" rid="F1">
                        1A</xref>). Interacting clones were selected on Leu-/Trp- media. Of the 158 colonies growing
                    under this selection, 35 were positive for lacZ expression. Sequence analysis revealed that 2 of the
                    3 clones were fragments of CPE, which was previously described as a sorting receptor to target
                    prohormones to the secretory granules of the regulated secretory pathway in neuroendocrine cells [
                    <xref ref-type="bibr" rid="B30">30</xref>].
                </p>
                <fig position="float" id="F1">
                    <label>Figure 1</label>
                    <caption>
                        <p><bold>Association of DAT with CPE</bold>.<bold>A</bold>, Using the Yeast 2-Hybrid System 3
                            (Invitrogen), 1.7 &#x000d7; 106 independent clones of a human substantia nigra library (in
                            pGAD10) were screened using DAT-NT, containing the amino terminus up to the first
                            transmembrane domain (TM1) and DAT-CT, containing the entire carboxyl terminus after the
                            12th transmembrane domain (TM12) as baits. Interacting clones were selected on media lacking
                            Leu, Trp, and His, in the presence of 2.5 mM 3-AT. Of 158 colonies growing under this
                            selection, 35 were positive for lacZ expression. Sequence analysis of these clones showed
                            that two of them represented fragments of carboxypeptidase E (CPE). One clone showing very
                            strong lacZ expression encoded a portion of CPE beginning at amino acid residue 123 of the
                            mature protein. No interaction was observed between CPE construct and Gal4 BD fused to
                            murine p53 or human lamina C or between any of the DAT-BD fusions and Gal4 AD fused to SV40
                            large T antigen.<bold>B</bold>, GST fusion protein precipitation assay using the complete C
                            and N terminus of DAT fused to GST. Aliquots containing GST fusion fragments were incubated
                            with rat striatal extracts and analyzed by Western blot using a polyclonal anti-CPE
                            antibody.<bold>C</bold>, Using an<italic>in vitro</italic>binding assay, [<sup>35</sup>
                            S]-CPE probe bound with GST-DAT-CT, but not with GST-DAT-NT or GST alone.<bold>D</bold>, DAT
                            coimmunoprecipitated with CPE antibodies from rat striatal extracts.
                        </p>
                    </caption>
                    <graphic xlink:href="1756-6606-2-10-1"/>
                </fig>
                <p>To further confirm the interaction between DAT and CPE, we performed GST affinity pull down assay
                    using purified GST fusion peptides containing sequences from DAT-CT (GST-DAT-CT). The results shown
                    in Fig.
                    <xref ref-type="fig" rid="F1">1B</xref>
                    demonstrated that GST-DAT-CT could selectively precipitate CPE from solubilized rat striatal tissue
                    whereas GST alone was unable to purify CPE. Moreover, to exclude the possibility of CPE
                    non-specifically binding to GST fusion peptides, intracellular N-terminal domain of DAT was also
                    employed as a control. As shown in Fig<xref ref-type="fig" rid="F1">1B</xref>, GST-DAT-NT was unable
                    to precipitate CPE, strongly suggesting that the interaction between DAT and CPE is mediated
                    specifically by the DAT-CT. While these results demonstrate the presence of the DAT: CPE protein
                    complex in rat striatal tissue, it does not clarify whether the DAT: CPE protein complex is formed
                    through a direct interaction or is mediated indirectly by an accessory binding protein.<italic>In
                        vitro</italic>binding assays were performed to provide evidence that DAT and CPE can directly
                    interact with each other. As shown in Figure<xref ref-type="fig" rid="F1">1C</xref>,<italic>in
                        vitro</italic>translated [<sup>35</sup>S]-CPE probe hybridized with GST-DAT-CT but not
                    GST-DAT-NT or GST alone, indicating the specificity of the direct protein-protein interaction
                    between CPE and DAT-CT. Taken together, these data suggest that CPE is involved in a direct
                    protein-protein interaction with DAT-CT.
                </p>
                <p>Next, we examined in solubilized rat striatum, whether DAT could coimmunopreicipiate with CPE thus
                    providing additional evidence of a physical association between DAT and CPE. As illustrated in Fig.
                    <xref ref-type="fig" rid="F1">1D</xref>, CPE antibodies co-precipitated a protein with a relative
                    molecular mass of 83 kDa that immunoreacted with DAT antibodies. Taken together, these results
                    showed that DAT could associate with CPE via the DAT-CT.
                </p>
            </sec>
            <sec>
                <title>Coexpression CPE and DAT increased the Vmax of DAT without effects on its affinity</title>
                <p>DAT plays a determinant role in dopaminergic neurotransmission by rapidly removing released dopamine
                    from the synaptic cleft. To explore the functional importance of the DAT-CPE interaction, we
                    examined the DAT-mediated DA uptake activity in HEK-293 cells coexpressing CPE. As illustrated in
                    Fig<xref ref-type="fig" rid="F2">2A</xref>, CPE coexpression significantly increased the maximal
                    uptake velocity (Vmax) of [<sup>3</sup>H] DA by ~50% (DAT: Vmax = 10.8 &#x000b1; 1 pmol/min/well;
                    DAT+CPE: 16 &#x000b1; 1.9 pmol/min/well;<italic>P</italic>&#x0003c; 0.01), whereas no significant
                    change in the estimated<italic>Km</italic>of the DAT could be observed (DAT:<italic>Km</italic>= 6.6
                    &#x000b1; 0.7 &#x003bc;M in cells expressing DAT vs 6.7 &#x000b1; 1.6 &#x003bc;M in cells expressing
                    DAT and CPE). To further exclude the possibility that Vmax differences might result from the
                    affinity changes, we performed [<sup>3</sup>H] WIN 35,428 competitive binding assay. As depicted in
                    Fig.
                    <xref ref-type="fig" rid="F2">2C</xref>
                    and<xref ref-type="fig" rid="F2">2D</xref>, the estimated affinity of DA at the ligand binding site
                    of DAT in CPE coexpressing cells was not significantly different from that observed for cells
                    expressing DAT alone (
                    <italic>IC</italic>
                    <sub>50</sub>= 986 &#x000b1; 24 nM in cells expressing DAT vs 1001 &#x000b1; 87 nM in cells
                    expressing DAT and CPE). The effect of CPE on DAT was not restricted to HEK-293 cells but was also
                    seen in COS-7 and Ltk- cells (data not show).
                </p>
                <fig position="float" id="F2">
                    <label>Figure 2</label>
                    <caption>
                        <p>
                            <bold>CPE-mediated enhancement of [<sup>3</sup>H] DA uptake
                            </bold>
                            .<bold>A</bold>, Representative saturation plots of [<sup>3</sup>H]DA uptake in HEK-293
                            cells expressing the DAT alone or coexpressing-CPE revealed an increase in the<italic>
                            Vmax</italic>for [<sup>3</sup>H] DA uptake accumulation (n = 9, P &#x0003c; 0.01) with no
                            significant alteration in estimated<italic>Km</italic>values (listed in the text).<bold>
                            B</bold>, CPE-mediated increase in [<sup>3</sup>H] DA uptake by DAT was blocked with the
                            coexpression of a minigene encoding the DAT-CT583&#x02013;620 peptide but did not alter the
                            uptake of cells expressing DAT alone (n = 4, P &#x0003c; 0.01).<bold>C</bold>,
                            Representative curves of the dose-dependent inhibition of [<sup>3</sup>H] WIN (4 nM) binding
                            by dopamine to DAT. Coexpression of CPE and DAT did not alter the estimated affinity value
                            of dopamine for DAT (IC50 values listed in the text).<bold>D</bold>, Estimated IC50 values
                            in control or CPE coexpressing cells. Values represent the means &#x000b1; SEM of 3&#x02013;9
                            independent experiments, each conducted in duplicate. Data were analyzed by ANOVA, followed
                            by<italic>post hoc</italic>Student-Newman-Keuls test. **, P &#x0003c; 0.01 compared with the
                            group cotransfected with DAT and pcDNA3; ##, P &#x0003c; 0.01 compared with the group
                            cotransfected with DAT and CPE.
                        </p>
                    </caption>
                    <graphic xlink:href="1756-6606-2-10-2"/>
                </fig>
                <p>Next, to confirm that the selective increase in maximal DAT-mediated DA uptake resulted from DAT-CPE
                    interaction, we tested whether a minigene (MG) encoding sequences of the DAT-CT could block these
                    effects, since coexpressioin of CT tail peptide would act as a competitive inhibitor to the CPE-DAT
                    interaction. As described in Fig.<xref ref-type="fig" rid="F2">2B</xref>, DAT-CT tail583&#x02013;620
                    MG cotransfected with DAT alone did not change either the Km or Vmax of cellular [<sup>3</sup>H] DA
                    uptake. However, coexpression of the MG encoding the peptide DAT-CT583&#x02013;620 significantly
                    inhibited the increasing effects of DAT-mediated DA translocation by CPE. Taken together, these data
                    indicated that the binding of DAT-CT tail583&#x02013;620 sequences to CPE was both sufficient and
                    necessary for the expression of CPE- mediated functional regulation of the DA translocation process.
                </p>
            </sec>
            <sec>
                <title>Regulation of DAT expression and trafficking by CPE</title>
                <p>Since no change in DA uptake affinity could be observed upon coexpression of CPE with DAT, the
                    increase in Vmax may reflect a change in the population of cell surface DAT. Therefore, we next
                    examined if DAT cell surface expression levels change upon coexpression of CPE by using a cell-based
                    ELISA assay to quantify changes at the cell surface and total DAT levels [<xref ref-type="bibr"
                                                                                                    rid="B27">27</xref>-
                    <xref ref-type="bibr" rid="B29">29</xref>]. As shown in Fig<xref ref-type="fig" rid="F3">3</xref>,
                    coexpression of CPE increased the levels of both total DAT and cell surface DAT to about ~20% (Fig.
                    <xref ref-type="fig" rid="F3">3A, B</xref>).
                </p>
                <fig position="float" id="F3">
                    <label>Figure 3</label>
                    <caption>
                        <p><bold>A, Summarized data indicating effects of CPE on DAT membrane expression in
                            cotransfected HEK-293 cells</bold>. Columns show the means &#x000b1; SEM of the ratios of
                            colorimetric readings under coexpression of DAT and pcDNA3 conditions versus coexpression of
                            DAT and CPE. **P &#x0003c; 0.01, n = 3 (Student's<italic>t</italic>test).<bold>B</bold>,
                            Summarized data indicating effects of CPE on DAT total expression including the
                            extracellular and intracellular ones in cotransfected HEK-293 cells. Columns show the means
                            &#x000b1; SEM of the ratios of colorimetric readings under coexpression of DAT and pcDNA3
                            conditions versus coexpression of DAT and CPE. **P &#x0003c; 0.01, n = 3 (Student's<italic>
                                t</italic>test).<bold>C</bold>, CPE colocalizes with DAT in HEK-293 cells. The
                            distribution pattern of DAT and CPE when expressed individually or coexpressed in HEK-293
                            cells are shown. Immunostaining was performed using the rabbit anti-DAT or the mouse
                            anti-CPE antibodies and secondary antibodies:CY3 anti-mouse (red) and FITC-conjugated
                            anti-rabbit antibodies (green). Yellow staining on the merged panels depicted
                            colocalization. No staining was observed when primary antibodies were eliminated. Data are
                            representative of 4&#x02013;6 independent experiments, with a total cell sampling of more
                            than 1000.<bold>D</bold>, Measurement of DAT protein metabolism by labeling with radioactive
                            amino acids. HEK-293 cells, into which the indicated genes had been transfected, acutely
                            incorporated 0.2 mCi/ml promix [<sup>35</sup>S]-methionine/cysteine for 4 h and were grown
                            in the complete medium for further 6, 12 and 24 h. DAT protein was immunoprecipitated from
                            the total protein by an anti-DAT polyclonal antibody. The antigen-antibody complex was
                            further analyzed on polyacrylamide gel and autoradiography was performed. The results were
                            repeated 3 times.
                        </p>
                    </caption>
                    <graphic xlink:href="1756-6606-2-10-3"/>
                </fig>
                <p>To directly examine the cellular effects of CPE on DAT, we analyzed subcellular localization of DAT
                    and CPE in transfected HEK-293 cells using confocal immunofluorescence microscopy. The results
                    showed that DAT and CPE displayed disperse distribution patterns when expressed separately in
                    HEK-293 cells. DAT could be found both at the cell surface and within cell, whereas CPE located
                    throughout the cytoplasm (Fig.<xref ref-type="fig" rid="F3">3A, B</xref>). However, when CPE and DAT
                    were cotransfected in HEK-293 cells, the distribution pattern of each protein changed dramatically,
                    with almost completely overlapping distribution at cell surface, as revealed by the merged confocal
                    immunofluorescence images (Fig.<xref ref-type="fig" rid="F3">3C</xref>). In virtually all cells
                    coexpressing DAT and CPE, DAT was largely found at the plasma membrane and colocalized with CPE
                    (Fig.<xref ref-type="fig" rid="F3">3C</xref>). These data suggested that CPE modulated DAT via a
                    posttranslational mechanism, which possibly included reduced degradation of surface DAT.
                </p>
                <p>Cell surface DAT may derive from newly synthesized DAT or from recycled DAT that have been
                    re-inserted into the membrane after being internalized. Thus, changes in both cell surface and total
                    DAT levels may reflect changes in DAT protein turnover rates in the presence of CPE. To test this
                    possibility, we carried out pulse-chase studies to examine DAT protein half-life in the presence of
                    CPE. As showed in Fig.<xref ref-type="fig" rid="F3">3D</xref>, in the absence of CPE, the
                    DAT-positive band was prominent at 6 hours but began to disappear at 12 hours and was completely
                    absent at 24 hours. However, coexpression of CPE inhibited the disappearance of the DAT-positive
                    band at 12 hours but was still completely degraded at 24 hours.
                </p>
            </sec>
            <sec>
                <title>CPE stablized DAT via reducing the phosphorylation state of DAT</title>
                <p>Cell surface expression and degradation of DAT [<xref ref-type="bibr" rid="B31">31</xref>] is
                    modulated by various cellular signals, substrates and neuronal activity. Among them, the best
                    characterized form of DAT regulation is phosphorylation [<xref ref-type="bibr" rid="B32">32</xref>].
                    Previous reports show that protein kinase C (PKC) down-regulates transporter activity via
                    internalization of DAT in several systems including striatal synaptosomes [<xref ref-type="bibr"
                                                                                                     rid="B33">33</xref>
                    ,<xref ref-type="bibr" rid="B34">34</xref>], slices [<xref ref-type="bibr" rid="B35">35</xref>] and
                    heterologous cells [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">
                        36</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Thus, the increased surface expression of
                    DAT by CPE may involve phosphorylation events. To explore this possibility, we first tested whether
                    CPE had any effect on the phosphrylation levels of DAT. As illustrated in Fig.<xref ref-type="fig"
                                                                                                        rid="F4">
                        4A</xref>, using an antibody that detected phosphorylated serines, immunoprecipitation of DAT
                    from COS-7 cells revealed a decrease in serine phosphorylation in cells coexpressing CPE. Reduced
                    phosphorylation state of DAT might reflect that association of CPE with DAT leaded to the occlusion
                    of PKC phosphorylation sites. We then examined the association between CPE and DAT under various
                    phosphorylation conditions. Rat striatum slices were treated with a PKC activator, phorbol
                    12-myristate 13-acetate (PMA) for 30 min before immunoprecipitation with the CPE antibody. As shown
                    in Fig<xref ref-type="fig" rid="F4">4B</xref>, PMA treatment reduced the association between CPE and
                    DAT as compared with non-treated COS-7 cells, implying that CPE preferentially interacted with
                    non-PKC phosphorylated forms of DAT.
                </p>
                <fig position="float" id="F4">
                    <label>Figure 4</label>
                    <caption>
                        <p><bold>CPE affects the phosphorylation state of DAT</bold>.<bold>A</bold>, COS-7 cells were
                            transiently transfected with DAT or together with CPE by using electroporation, grown for 3&#x02013;4
                            days, and was collected to be homogenized. The cells lysates was immunoprecipitated with
                            anti-DAT antibody overnight. Subsequent western blotting of SDS-PAGE immunoprecipitaed
                            samples with polyclonal anti-phosphoserine antibody and reimmunoblotting the membrane with
                            anti-DAT antibody.<bold>B</bold>, Phosphorylation state of DAT affected the interaction
                            between DAT and CPE. Striatal slices were pretreated for 30 min with 2 &#x003bc;M PMA before
                            immunoprecipitation with the DAT antibody. Subsequent western blotting of SDS-PAGE
                            immunoprecipitaed samples were incubated with anti DAT or anti CPE antibody.
                        </p>
                    </caption>
                    <graphic xlink:href="1756-6606-2-10-4"/>
                </fig>
            </sec>
            <sec>
                <title>CPE modulated the function of DAT through surface phosphorylation and expression</title>
                <p>To provide further evidence that the expression and functional affects on DAT were mediated by
                    phosphorylation changes induced by the CPE-DAT interaction, we explored the relationship of DAT
                    phosphorylation with DA translocation velocity and surface expression under phosphorylating
                    conditions mentioned above. As depicted in Fig<xref ref-type="fig" rid="F5">5A</xref>, PMA treatment
                    significantly reduced the increasing effects of CPE on DAT-induced DA translocation velocity.
                    Moreover, the changes of Vmax levels coincided with both the total and surface expression levels of
                    DAT (Fig<xref ref-type="fig" rid="F5">5B</xref>); strongly suggesting that PMA reduced the effects
                    of CPE probably through increased internalization via phosphorylation.
                </p>
                <fig position="float" id="F5">
                    <label>Figure 5</label>
                    <caption>
                        <p><bold>CPE reserves PKC-mediated inhibition of DAT uptake and cell surface expression</bold>.
                            <bold>A</bold>, Uptake of [<sup>3</sup>H] DA in HEK-293 cells after a 30-min incubation at
                            37&#x000b0;C with vehicle alone (uptake buffer) or 2 &#x003bc;M PMA. Values are the
                            percentage of uptake activity compared with untreated cells &#x000b1; SEM. Data were
                            analyzed by ANOVA, followed by<italic>post hoc</italic>Student-Newman-Keuls test. **, P
                            &#x0003c; 0.01 compared with the group cotransfected with DAT and pcDNA3; ##, P &#x0003c;
                            0.01 compared with the group cotransfected with DAT and CPE untreated with PMA, n = 3.<bold>
                                B</bold>, Summarized data indicating effects of CPE on DAT membrane expression in
                            cotransfected HEK-293 cells after 30-min incubation at 37&#x000b0;C with vehicle alone
                            (uptake buffer) or 2 &#x003bc;M PMA. Columns show the means &#x000b1; SEM of the ratios of
                            colorimetric readings. Data were analyzed by ANOVA, followed by<italic>post hoc</italic>
                            Student-Newman-Keuls test. **, P &#x0003c; 0.01 compared with the group cotransfected with
                            DAT and pcDNA3; ##, P &#x0003c; 0.01 compared with the group cotransfected with DAT and CPE
                            untreated with PMA, n = 3.
                        </p>
                    </caption>
                    <graphic xlink:href="1756-6606-2-10-5"/>
                </fig>
            </sec>
        </sec>
        <sec>
            <title>Discussion</title>
            <p>Recent studies have identified new properties of the DAT, including the regulation of cell excitability
                through leak current conductance and channel mechanism [<xref ref-type="bibr" rid="B38">38</xref>,<xref
                        ref-type="bibr" rid="B39">39</xref>], as well as serving as a pathway for substrate-induced
                dopamine release at both axonal and dendritic sites [<xref ref-type="bibr" rid="B40">40</xref>].
                However, each cellular role currently associated with the DAT depends on plasma membrane expression. In
                the present study, we provided biochemical evidence for a physical interaction between CPE and DAT via
                the DAT-CT. We have shown that this interaction leads to cell surface stabilization of DAT via reduced
                degradation, possibly through a reduction in DAT phosphorylation. In addition, immunofluorescence
                analysis demonstrated that co-expression of CPE and DAT facilitated surface translocation of both
                proteins. Functional assays showed that the increased surface DAT led to a corresponding increase in DA
                uptake but had no effect on DAT affinity for DA. Finally, mini-gene encoding the DAT CT blocked CPE's
                effects. We concluded that CPE-mediated modulation of DAT trafficking, membrane expression and
                phosphorylation was facilitated by the CPE-DAT physical coupling.
            </p>
            <p>The present finding highlighted the importance of CPE in trafficking and metabolic processing of DAT. DAT
                undergoes cyclical traffic to and from the plasma membrane and changes in transporter surface
                presentation can result from modulating endocytosis, recycling or de novo biosynthesis. Coexpression of
                CPE with DAT changed the diffuse DAT expression throughout the cell to stronger plasma membrane
                localization and suggests the interaction occur intracellularlly. CPE exists in both a soluble form and
                a membrane form [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>].
                Soluble forms of CPE function as an exopeptidase to cleave proneuropeptides within the lumen of the
                vesicle and yield biologically active peptides [<xref ref-type="bibr" rid="B43">43</xref>,<xref
                        ref-type="bibr" rid="B44">44</xref>], whereas membrane from of CPE is associated with lipid
                rafts and exist in a transmembrane orientation in secretory granules as a sorting receptor [<xref
                        ref-type="bibr" rid="B45">45</xref>]. During proteolytic processing of peptide precursor, CPE
                normally removes the C-terminal basic residues on the processing intermediates after the action of
                prohormone convertases on the peptide precursor [<xref ref-type="bibr" rid="B46">46</xref>]. In many
                cases, as a final step in the biosynthesis of neuropeptides, CPE recognizes and cleaves the Arg/Lys
                paired basic residues at the COOH-terminal side to generate the final neuropeptide. Thus, the exact
                nature of CPE-DAT association, how and where this interaction takes place intracellularly remains to be
                determined.
            </p>
            <p>Although not in paired form, Arg/Lys residues are also present in the C-terminus of hDAT, rendering the
                possibility that CPE would be involved in the processing of DAT. Interestingly, CPE band did show a
                slightly lower on pulse-chase assay coexpressed with DAT, which deserved further investigation.
                Immunogold labeling detects DAT in tubulo-vesicular structures and small electron-lucent vesicles in
                dopaminergic neurons from the dorsal striatum and nucleus accumbens [<xref ref-type="bibr" rid="B8">
                    8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Also, both ultrastructural and biochemical
                studies revealed the localization of DAT in endosomes and tubulo-vesicular membranes but not
                biosynthetic machinery, suggesting that most of intracellular DAT- positive vesicles are endocytic but
                not secretory [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B37">37</xref>].
                Interestingly, the membrane form of CPE has been demonstrated to bind to POMC [<xref ref-type="bibr"
                                                                                                     rid="B30">30</xref>
                ] and BDNF [<xref ref-type="bibr" rid="B41">41</xref>], sorting these precursors at the trans-Golgi
                network (TGN) into vesicles of the regulated secretory pathway in pituitary cells and hippocampal
                neurons, respectively. Previous results show that secretory and endocytic pathways converge forming the
                TGN, an intricate system of tubulovesicular membranes, the main site for sorting secretory vesicles and
                transports proteins including DAT [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr"
                                                                                                 rid="B11">11</xref>,
                <xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>] and for
                specifically targeting synaptic membrane receptors into dendrites [<xref ref-type="bibr" rid="B49">
                    49</xref>]. Moreover, the TGN is known to interact with the recycling endosomal system in
                hippocampal neurons [<xref ref-type="bibr" rid="B50">50</xref>]. Thus, the co-localization of these two
                proteins in TGN may be the potential site where the CPE-DAT interaction occurs.
            </p>
            <p>DAT possesses consensus sequences for phosphorylation by protein kinases [<xref ref-type="bibr" rid="B6">
                6</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B51">51</xref>,<xref
                    ref-type="bibr" rid="B52">52</xref>] including cAMP-dependent protein kinsase, protein kinase C
                (PKC), Ca2+/calmodulin-dependent protein kinase, MAP kinase and tyrosine kinase. Several studies have
                shown that regulation of kinase activity in striatal synaptosomal preparations and heterologous cell
                expression systems affects DAT uptake activity [<xref ref-type="bibr" rid="B12">12</xref>], which is
                believed to result from a rapid redistribution of transporter from the cell membrane to intracellular
                compartments, rather than changes in the intrinsic transport activity [<xref ref-type="bibr" rid="B31">
                    31</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B53">53</xref>,<xref
                        ref-type="bibr" rid="B54">54</xref>]. This phosphorylation/dephosphorylation status is closely
                coupled to DAT endocytic trafficking and interestingly PKC activation has been shown to decrease DAT
                activity through clathrin-mediated endocytosis [<xref ref-type="bibr" rid="B31">31</xref>,<xref
                        ref-type="bibr" rid="B55">55</xref>], an event associated with an increase in DAT
                phosphorylation [<xref ref-type="bibr" rid="B52">52</xref>]. This is in agreement with our studies in
                which CPE decreases DAT phosphorylation leading to slower degradation and increase cell surface
                localization. However, there have been reports that PKC-induced phosphorylation of the DAT itself is not
                required for PKC-induced DAT sequestration [<xref ref-type="bibr" rid="B56">56</xref>], leading to the
                possibility that DAT are trapped in its phosphorylated state in subcellular compartment, where CPE may
                speed up the assorting and recycling back to the membrane of the internalized DAT.
            </p>
            <p>The exact mechanism for CPE's effects on DAT phosphorylation and its relationship with cell surface DAT
                expression require further investigation. Foster and colleagues recently report that the amino terminus
                of DAT, which contains a cluster of serine residues, is the primary site of phosphorylation by PKC [
                <xref ref-type="bibr" rid="B35">35</xref>]. It is possible that the interaction with CPE may mask the
                PKC phosphorylation site on DAT. Indeed, it has been proposed that transporter-interacting proteins
                might directly or indirectly regulate kinase-dependent effects on DAT activity [<xref ref-type="bibr"
                                                                                                      rid="B57">
                    57</xref>]. Alternatively, there is evidence that PKC- mediated functional regulation of DAT is not
                achieved by direct phosphorylation of the DAT protein [<xref ref-type="bibr" rid="B58">58</xref>], as
                has been demonstrated for the GABA transporter, where PKC down regulates transporter function by
                modulating the association of syntaxin with the transporter [<xref ref-type="bibr" rid="B59">59</xref>].
                Moreover, other yet-to-be-identified proteins may also play a role in regulating DAT function. Blakely
                and colleagues found that the protein phosphatase 2A (PP2A) could be co-immunoprecipitated from brain
                tissue with DAT, NET, or SERT proteins [<xref ref-type="bibr" rid="B60">60</xref>]. In the case of SERT,
                the interaction with PP2A was dynamically regulated by phosphatase inhibition, PKC activation and
                transporter substrates. Although it is not known whether PP2A binds directly to monoamine transporters,
                this association might help to explain the molecular events that are responsible for transporter
                phosphorylation and internalization
            </p>
        </sec>
        <sec>
            <title>Conclusion</title>
            <p>Taken together, data from our present study and previous reports indicate that protein-protein
                interactions appear to be important for DAT function. The association of DAT with CPE may have critical
                impact on DAT phosphorylation state and be involved in cyclic trafficking. While our findings shed new
                light on the trafficking mechanisms of DAT, several questions still remain to be addressed. It remains
                to be determined in which cellular compartment this interaction occurs and the details of mechanisms
                involved that may regulate the CPE-DAT interaction. Furthermore, both CPE and the DAT may have roles in
                obesity and it will be interesting to investigate if this interaction contributes to the pathophysiology
                of this disease. Further investigation into characterizing this interaction and understanding the
                regulatory factors involved, will lead to a better understanding of DAT trafficking and may have
                important physiological and pathophysiological implications.
            </p>
        </sec>
        <sec>
            <title>Competing interests</title>
            <p>The authors declare that they have no competing interests.</p>
        </sec>
        <sec>
            <title>Authors' contributions</title>
            <p>HZ carried out all experiments, with the exception of the in vitro binding, the uptake assay, WIN binding
                and the assays of the phosphorylation level of DAT. SL conducted the immunoassays of the phosphorylation
                level of DAT and contribute to the writing of the manuscript. MW participated in the in vitro binding
                and helped to draft the manuscript. BV participated in the cell culture and performed the statistical
                analysis. ZBP provided the cDNA of the dopamine transporter and conducted the dopamine uptake and WIN
                binding assays. FL conceived of the study, and participated in its design and wrote the manuscript. All
                authors read and approved the final manuscript.
            </p>
        </sec>
    </body>
    <back>
        <ack>
            <sec>
                <title>Acknowledgements</title>
                <p>FL is a recipient of Operating Grant of the Canadian Institute of Health Research. The work is
                    supported by Canadian Institute of Health Research (FL). The in vivo studies were supported by
                    BioDiscovery Toronto.
                </p>
            </sec>
        </ack>
        <ref-list>
            <ref id="B1">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Amara</surname>
                            <given-names>SG</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                    </person-group>
                    <article-title>Neurotransmitter transporters: recent progress</article-title>
                    <source>Annu Rev Neurosci</source>
                    <year>1993</year>
                    <volume>16</volume>
                    <fpage>73</fpage>
                    <lpage>93</lpage>
                    <pub-id pub-id-type="pmid">8096377</pub-id>
                </citation>
            </ref>
            <ref id="B2">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Norregaard</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Gether</surname>
                            <given-names>U</given-names>
                        </name>
                    </person-group>
                    <article-title>The monoamine neurotransmitter transporters: structure, conformational changes and
                        molecular gating
                    </article-title>
                    <source>Curr Opin Drug Discov Devel</source>
                    <year>2001</year>
                    <volume>4</volume>
                    <fpage>591</fpage>
                    <lpage>601</lpage>
                    <pub-id pub-id-type="pmid">12825454</pub-id>
                </citation>
            </ref>
            <ref id="B3">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gether</surname>
                            <given-names>U</given-names>
                        </name>
                        <name>
                            <surname>Andersen</surname>
                            <given-names>PH</given-names>
                        </name>
                        <name>
                            <surname>Larsson</surname>
                            <given-names>OM</given-names>
                        </name>
                        <name>
                            <surname>Schousboe</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>
                    <article-title>Neurotransmitter transporters: molecular function of important drug targets
                    </article-title>
                    <source>Trends Pharmacol Sci</source>
                    <year>2006</year>
                    <volume>27</volume>
                    <fpage>375</fpage>
                    <lpage>383</lpage>
                    <pub-id pub-id-type="pmid">16762425</pub-id>
                </citation>
            </ref>
            <ref id="B4">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chen</surname>
                            <given-names>N</given-names>
                        </name>
                        <name>
                            <surname>Reith</surname>
                            <given-names>ME</given-names>
                        </name>
                    </person-group>
                    <article-title>Structure and function of the dopamine transporter</article-title>
                    <source>Eur J Pharmacol</source>
                    <year>2000</year>
                    <volume>405</volume>
                    <fpage>329</fpage>
                    <lpage>339</lpage>
                    <pub-id pub-id-type="pmid">11033338</pub-id>
                </citation>
            </ref>
            <ref id="B5">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bannon</surname>
                            <given-names>MJ</given-names>
                        </name>
                    </person-group>
                    <article-title>The dopamine transporter: role in neurotoxicity and human disease</article-title>
                    <source>Toxicol Appl Pharmacol</source>
                    <year>2005</year>
                    <volume>204</volume>
                    <fpage>355</fpage>
                    <lpage>360</lpage>
                    <pub-id pub-id-type="pmid">15845424</pub-id>
                </citation>
            </ref>
            <ref id="B6">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                        <name>
                            <surname>Sorkin</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>
                    <article-title>Rapid regulation of the dopamine transporter: role in stimulant addiction?
                    </article-title>
                    <source>Neuropharmacology</source>
                    <year>2004</year>
                    <volume>47</volume>
                    <fpage>80</fpage>
                    <lpage>91</lpage>
                    <pub-id pub-id-type="pmid">15464127</pub-id>
                </citation>
            </ref>
            <ref id="B7">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Torres</surname>
                            <given-names>GE</given-names>
                        </name>
                        <name>
                            <surname>Carneiro</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Seamans</surname>
                            <given-names>K</given-names>
                        </name>
                        <name>
                            <surname>Fiorentini</surname>
                            <given-names>C</given-names>
                        </name>
                        <name>
                            <surname>Sweeney</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Yao</surname>
                            <given-names>WD</given-names>
                        </name>
                        <name>
                            <surname>Caron</surname>
                            <given-names>MG</given-names>
                        </name>
                    </person-group>
                    <article-title>Oligomerization and trafficking of the human dopamine transporter. Mutational
                        analysis identifies critical domains important for the functional expression of the transporter
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>2003</year>
                    <volume>278</volume>
                    <fpage>2731</fpage>
                    <lpage>2739</lpage>
                    <pub-id pub-id-type="pmid">12429746</pub-id>
                </citation>
            </ref>
            <ref id="B8">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nirenberg</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Uhl</surname>
                            <given-names>GR</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Pickel</surname>
                            <given-names>VM</given-names>
                        </name>
                    </person-group>
                    <article-title>The dopamine transporter is localized to dendritic and axonal plasma membranes of
                        nigrostriatal dopaminergic neurons
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1996</year>
                    <volume>16</volume>
                    <fpage>436</fpage>
                    <lpage>447</lpage>
                    <pub-id pub-id-type="pmid">8551328</pub-id>
                </citation>
            </ref>
            <ref id="B9">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nirenberg</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Chan</surname>
                            <given-names>J</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Uhl</surname>
                            <given-names>GR</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Pickel</surname>
                            <given-names>VM</given-names>
                        </name>
                    </person-group>
                    <article-title>Immunogold localization of the dopamine transporter: an ultrastructural study of the
                        rat ventral tegmental area
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1997</year>
                    <volume>17</volume>
                    <fpage>5255</fpage>
                    <lpage>5262</lpage>
                    <pub-id pub-id-type="pmid">9204909</pub-id>
                </citation>
            </ref>
            <ref id="B10">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nirenberg</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Chan</surname>
                            <given-names>J</given-names>
                        </name>
                        <name>
                            <surname>Pohorille</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Uhl</surname>
                            <given-names>GR</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Pickel</surname>
                            <given-names>VM</given-names>
                        </name>
                    </person-group>
                    <article-title>The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic
                        and motor compartments of the nucleus accumbens
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1997</year>
                    <volume>17</volume>
                    <fpage>6899</fpage>
                    <lpage>6907</lpage>
                    <pub-id pub-id-type="pmid">9278525</pub-id>
                </citation>
            </ref>
            <ref id="B11">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schroeter</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Apparsundaram</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Wiley</surname>
                            <given-names>RG</given-names>
                        </name>
                        <name>
                            <surname>Miner</surname>
                            <given-names>LH</given-names>
                        </name>
                        <name>
                            <surname>Sesack</surname>
                            <given-names>SR</given-names>
                        </name>
                        <name>
                            <surname>Blakely</surname>
                            <given-names>RD</given-names>
                        </name>
                    </person-group>
                    <article-title>Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine
                        transporter
                    </article-title>
                    <source>J Comp Neurol</source>
                    <year>2000</year>
                    <volume>420</volume>
                    <fpage>211</fpage>
                    <lpage>232</lpage>
                    <pub-id pub-id-type="pmid">10753308</pub-id>
                </citation>
            </ref>
            <ref id="B12">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                        <name>
                            <surname>Doolen</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>
                    <article-title>Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters:
                        drugs, substrates, presynaptic receptors, and signaling systems
                    </article-title>
                    <source>Pharmacol Ther</source>
                    <year>2001</year>
                    <volume>92</volume>
                    <fpage>21</fpage>
                    <lpage>55</lpage>
                    <pub-id pub-id-type="pmid">11750035</pub-id>
                </citation>
            </ref>
            <ref id="B13">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gulley</surname>
                            <given-names>JM</given-names>
                        </name>
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                    </person-group>
                    <article-title>Rapid regulation of dopamine transporter function by substrates, blockers and
                        presynaptic receptor ligands
                    </article-title>
                    <source>Eur J Pharmacol</source>
                    <year>2003</year>
                    <volume>479</volume>
                    <fpage>139</fpage>
                    <lpage>152</lpage>
                    <pub-id pub-id-type="pmid">14612145</pub-id>
                </citation>
            </ref>
            <ref id="B14">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Melikian</surname>
                            <given-names>HE</given-names>
                        </name>
                    </person-group>
                    <article-title>Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation
                    </article-title>
                    <source>Pharmacol Ther</source>
                    <year>2004</year>
                    <volume>104</volume>
                    <fpage>17</fpage>
                    <lpage>27</lpage>
                    <pub-id pub-id-type="pmid">15500906</pub-id>
                </citation>
            </ref>
            <ref id="B15">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Pristupa</surname>
                            <given-names>ZB</given-names>
                        </name>
                        <name>
                            <surname>Ciliax</surname>
                            <given-names>BJ</given-names>
                        </name>
                        <name>
                            <surname>Levey</surname>
                            <given-names>AI</given-names>
                        </name>
                        <name>
                            <surname>Niznik</surname>
                            <given-names>HB</given-names>
                        </name>
                    </person-group>
                    <article-title>The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants
                        selectively confer high affinity dopamine uptake while attenuating recognition of the ligand
                        binding domain
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>1996</year>
                    <volume>271</volume>
                    <fpage>20885</fpage>
                    <lpage>20894</lpage>
                    <pub-id pub-id-type="pmid">8702845</pub-id>
                </citation>
            </ref>
            <ref id="B16">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Torres</surname>
                            <given-names>GE</given-names>
                        </name>
                        <name>
                            <surname>Yao</surname>
                            <given-names>WD</given-names>
                        </name>
                        <name>
                            <surname>Mohn</surname>
                            <given-names>AR</given-names>
                        </name>
                        <name>
                            <surname>Quan</surname>
                            <given-names>H</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>KM</given-names>
                        </name>
                        <name>
                            <surname>Levey</surname>
                            <given-names>AI</given-names>
                        </name>
                        <name>
                            <surname>Staudinger</surname>
                            <given-names>J</given-names>
                        </name>
                        <name>
                            <surname>Caron</surname>
                            <given-names>MG</given-names>
                        </name>
                    </person-group>
                    <article-title>Functional interaction between monoamine plasma membrane transporters and the
                        synaptic PDZ domain-containing protein PICK1
                    </article-title>
                    <source>Neuron</source>
                    <year>2001</year>
                    <volume>30</volume>
                    <fpage>121</fpage>
                    <lpage>134</lpage>
                    <pub-id pub-id-type="pmid">11343649</pub-id>
                </citation>
            </ref>
            <ref id="B17">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Carneiro</surname>
                            <given-names>AM</given-names>
                        </name>
                        <name>
                            <surname>Ingram</surname>
                            <given-names>SL</given-names>
                        </name>
                        <name>
                            <surname>Beaulieu</surname>
                            <given-names>JM</given-names>
                        </name>
                        <name>
                            <surname>Sweeney</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Amara</surname>
                            <given-names>SG</given-names>
                        </name>
                        <name>
                            <surname>Thomas</surname>
                            <given-names>SM</given-names>
                        </name>
                        <name>
                            <surname>Caron</surname>
                            <given-names>MG</given-names>
                        </name>
                        <name>
                            <surname>Torres</surname>
                            <given-names>GE</given-names>
                        </name>
                    </person-group>
                    <article-title>The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and
                        interacts with the dopamine transporter
                    </article-title>
                    <source>J Neurosci</source>
                    <year>2002</year>
                    <volume>22</volume>
                    <fpage>7045</fpage>
                    <lpage>7054</lpage>
                    <pub-id pub-id-type="pmid">12177201</pub-id>
                </citation>
            </ref>
            <ref id="B18">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                        <name>
                            <surname>Pristupa</surname>
                            <given-names>ZB</given-names>
                        </name>
                        <name>
                            <surname>Niznik</surname>
                            <given-names>HB</given-names>
                        </name>
                    </person-group>
                    <article-title>Direct binding and functional coupling of alpha-synuclein to the dopamine
                        transporters accelerate dopamine-induced apoptosis
                    </article-title>
                    <source>FASEB J</source>
                    <year>2001</year>
                    <volume>15</volume>
                    <fpage>916</fpage>
                    <lpage>926</lpage>
                    <pub-id pub-id-type="pmid">11292651</pub-id>
                </citation>
            </ref>
            <ref id="B19">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sorkina</surname>
                            <given-names>T</given-names>
                        </name>
                        <name>
                            <surname>Doolen</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Galperin</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                        <name>
                            <surname>Sorkin</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>
                    <article-title>Oligomerization of dopamine transporters visualized in living cells by fluorescence
                        resonance energy transfer microscopy
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>2003</year>
                    <volume>278</volume>
                    <fpage>28274</fpage>
                    <lpage>28283</lpage>
                    <pub-id pub-id-type="pmid">12746456</pub-id>
                </citation>
            </ref>
            <ref id="B20">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>KH</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>MY</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>DH</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>YS</given-names>
                        </name>
                    </person-group>
                    <article-title>Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region
                        of human dopamine transporter
                    </article-title>
                    <source>Neurochem Res</source>
                    <year>2004</year>
                    <volume>29</volume>
                    <fpage>1405</fpage>
                    <lpage>1409</lpage>
                    <pub-id pub-id-type="pmid">15202772</pub-id>
                </citation>
            </ref>
            <ref id="B21">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bolan</surname>
                            <given-names>EA</given-names>
                        </name>
                        <name>
                            <surname>Kivell</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Jaligam</surname>
                            <given-names>V</given-names>
                        </name>
                        <name>
                            <surname>Oz</surname>
                            <given-names>M</given-names>
                        </name>
                        <name>
                            <surname>Jayanthi</surname>
                            <given-names>LD</given-names>
                        </name>
                        <name>
                            <surname>Han</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Sen</surname>
                            <given-names>N</given-names>
                        </name>
                        <name>
                            <surname>Urizar</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Gomes</surname>
                            <given-names>I</given-names>
                        </name>
                        <name>
                            <surname>Devi</surname>
                            <given-names>LA</given-names>
                        </name>
                        <etal></etal>
                    </person-group>
                    <article-title>D2 receptors regulate dopamine transporter function via an extracellular
                        signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism
                    </article-title>
                    <source>Mol Pharmacol</source>
                    <year>2007</year>
                    <volume>71</volume>
                    <fpage>1222</fpage>
                    <lpage>1232</lpage>
                    <pub-id pub-id-type="pmid">17267664</pub-id>
                </citation>
            </ref>
            <ref id="B22">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Pei</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Moszczynska</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Vukusic</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Fletcher</surname>
                            <given-names>PJ</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                    </person-group>
                    <article-title>Dopamine transporter cell surface localization facilitated by a direct interaction
                        with the dopamine D2 receptor
                    </article-title>
                    <source>EMBO J</source>
                    <year>2007</year>
                    <volume>26</volume>
                    <fpage>2127</fpage>
                    <lpage>2136</lpage>
                    <pub-id pub-id-type="pmid">17380124</pub-id>
                </citation>
            </ref>
            <ref id="B23">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Marazziti</surname>
                            <given-names>D</given-names>
                        </name>
                        <name>
                            <surname>Mandillo</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Di Pietro</surname>
                            <given-names>C</given-names>
                        </name>
                        <name>
                            <surname>Golini</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Matteoni</surname>
                            <given-names>R</given-names>
                        </name>
                        <name>
                            <surname>Tocchini-Valentini</surname>
                            <given-names>GP</given-names>
                        </name>
                    </person-group>
                    <article-title>GPR37 associates with the dopamine transporter to modulate dopamine uptake and
                        behavioral responses to dopaminergic drugs
                    </article-title>
                    <source>Proc Natl Acad Sci USA</source>
                    <year>2007</year>
                    <volume>104</volume>
                    <fpage>9846</fpage>
                    <lpage>9851</lpage>
                    <pub-id pub-id-type="pmid">17519329</pub-id>
                </citation>
            </ref>
            <ref id="B24">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zapata</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Kivell</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Han</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Javitch</surname>
                            <given-names>JA</given-names>
                        </name>
                        <name>
                            <surname>Bolan</surname>
                            <given-names>EA</given-names>
                        </name>
                        <name>
                            <surname>Kuraguntla</surname>
                            <given-names>D</given-names>
                        </name>
                        <name>
                            <surname>Jaligam</surname>
                            <given-names>V</given-names>
                        </name>
                        <name>
                            <surname>Oz</surname>
                            <given-names>M</given-names>
                        </name>
                        <name>
                            <surname>Jayanthi</surname>
                            <given-names>LD</given-names>
                        </name>
                        <name>
                            <surname>Samuvel</surname>
                            <given-names>DJ</given-names>
                        </name>
                        <etal></etal>
                    </person-group>
                    <article-title>Regulation of dopamine transporter function and cell surface expression by D3
                        dopamine receptors
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>2007</year>
                    <volume>282</volume>
                    <fpage>35842</fpage>
                    <lpage>35854</lpage>
                    <pub-id pub-id-type="pmid">17923483</pub-id>
                </citation>
            </ref>
            <ref id="B25">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cen</surname>
                            <given-names>X</given-names>
                        </name>
                        <name>
                            <surname>Nitta</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Ibi</surname>
                            <given-names>D</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Niwa</surname>
                            <given-names>M</given-names>
                        </name>
                        <name>
                            <surname>Taguchi</surname>
                            <given-names>K</given-names>
                        </name>
                        <name>
                            <surname>Hamada</surname>
                            <given-names>M</given-names>
                        </name>
                        <name>
                            <surname>Ito</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Nabeshima</surname>
                            <given-names>T</given-names>
                        </name>
                    </person-group>
                    <article-title>Identification of Piccolo as a regulator of behavioral plasticity and dopamine
                        transporter internalization
                    </article-title>
                    <source>Mol Psychiatry</source>
                    <year>2008</year>
                    <volume>13</volume>
                    <fpage>349, 451</fpage>
                    <lpage>463</lpage>
                    <pub-id pub-id-type="pmid">18195717</pub-id>
                </citation>
            </ref>
            <ref id="B26">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Torres</surname>
                            <given-names>GE</given-names>
                        </name>
                    </person-group>
                    <article-title>The dopamine transporter proteome</article-title>
                    <source>J Neurochem</source>
                    <year>2006</year>
                    <volume>97</volume>
                    <fpage>3</fpage>
                    <lpage>10</lpage>
                    <pub-id pub-id-type="pmid">16635244</pub-id>
                </citation>
            </ref>
            <ref id="B27">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Xue</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Pei</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Vukusic</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Chery</surname>
                            <given-names>N</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>YT</given-names>
                        </name>
                        <name>
                            <surname>Niznik</surname>
                            <given-names>HB</given-names>
                        </name>
                        <name>
                            <surname>Yu</surname>
                            <given-names>XM</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                    </person-group>
                    <article-title>Dual regulation of NMDA receptor functions by direct protein-protein interactions
                        with the dopamine D1 receptor
                    </article-title>
                    <source>Cell</source>
                    <year>2002</year>
                    <volume>111</volume>
                    <fpage>219</fpage>
                    <lpage>230</lpage>
                    <pub-id pub-id-type="pmid">12408866</pub-id>
                </citation>
            </ref>
            <ref id="B28">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                        <name>
                            <surname>Wan</surname>
                            <given-names>Q</given-names>
                        </name>
                        <name>
                            <surname>Pristupa</surname>
                            <given-names>ZB</given-names>
                        </name>
                        <name>
                            <surname>Yu</surname>
                            <given-names>XM</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>YT</given-names>
                        </name>
                        <name>
                            <surname>Niznik</surname>
                            <given-names>HB</given-names>
                        </name>
                    </person-group>
                    <article-title>Direct protein-protein coupling enables cross-talk between dopamine D5 and
                        gamma-aminobutyric acid A receptors
                    </article-title>
                    <source>Nature</source>
                    <year>2000</year>
                    <volume>403</volume>
                    <fpage>274</fpage>
                    <lpage>280</lpage>
                    <pub-id pub-id-type="pmid">10659839</pub-id>
                </citation>
            </ref>
            <ref id="B29">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pei</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Moszczynska</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>Vukusic</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                    </person-group>
                    <article-title>Regulation of dopamine D1 receptor function by physical interaction with the NMDA
                        receptors
                    </article-title>
                    <source>J Neurosci</source>
                    <year>2004</year>
                    <volume>24</volume>
                    <fpage>1149</fpage>
                    <lpage>1158</lpage>
                    <pub-id pub-id-type="pmid">14762133</pub-id>
                </citation>
            </ref>
            <ref id="B30">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cool</surname>
                            <given-names>DR</given-names>
                        </name>
                        <name>
                            <surname>Normant</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Shen</surname>
                            <given-names>F</given-names>
                        </name>
                        <name>
                            <surname>Chen</surname>
                            <given-names>HC</given-names>
                        </name>
                        <name>
                            <surname>Pannell</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>Zhang</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Loh</surname>
                            <given-names>YP</given-names>
                        </name>
                    </person-group>
                    <article-title>Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic
                        obliteration leads to endocrine disorders in Cpe(fat) mice
                    </article-title>
                    <source>Cell</source>
                    <year>1997</year>
                    <volume>88</volume>
                    <fpage>73</fpage>
                    <lpage>83</lpage>
                    <pub-id pub-id-type="pmid">9019408</pub-id>
                </citation>
            </ref>
            <ref id="B31">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Daniels</surname>
                            <given-names>GM</given-names>
                        </name>
                        <name>
                            <surname>Amara</surname>
                            <given-names>SG</given-names>
                        </name>
                    </person-group>
                    <article-title>Regulated trafficking of the human dopamine transporter. Clathrin-mediated
                        internalization and lysosomal degradation in response to phorbol esters
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>1999</year>
                    <volume>274</volume>
                    <fpage>35794</fpage>
                    <lpage>35801</lpage>
                    <pub-id pub-id-type="pmid">10585462</pub-id>
                </citation>
            </ref>
            <ref id="B32">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Eisenhofer</surname>
                            <given-names>G</given-names>
                        </name>
                    </person-group>
                    <article-title>The role of neuronal and extraneuronal plasma membrane transporters in the
                        inactivation of peripheral catecholamines
                    </article-title>
                    <source>Pharmacol Ther</source>
                    <year>2001</year>
                    <volume>91</volume>
                    <fpage>35</fpage>
                    <lpage>62</lpage>
                    <pub-id pub-id-type="pmid">11707293</pub-id>
                </citation>
            </ref>
            <ref id="B33">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Copeland</surname>
                            <given-names>BJ</given-names>
                        </name>
                        <name>
                            <surname>Vogelsberg</surname>
                            <given-names>V</given-names>
                        </name>
                        <name>
                            <surname>Neff</surname>
                            <given-names>NH</given-names>
                        </name>
                        <name>
                            <surname>Hadjiconstantinou</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein kinase C activators decrease dopamine uptake into striatal synaptosomes
                    </article-title>
                    <source>J Pharmacol Exp Ther</source>
                    <year>1996</year>
                    <volume>277</volume>
                    <fpage>1527</fpage>
                    <lpage>1532</lpage>
                    <pub-id pub-id-type="pmid">8667219</pub-id>
                </citation>
            </ref>
            <ref id="B34">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Huff</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Uhl</surname>
                            <given-names>GR</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein kinase C-mediated phosphorylation and functional regulation of dopamine
                        transporters in striatal synaptosomes
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>1997</year>
                    <volume>272</volume>
                    <fpage>15541</fpage>
                    <lpage>15546</lpage>
                    <pub-id pub-id-type="pmid">9182590</pub-id>
                </citation>
            </ref>
            <ref id="B35">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Foster</surname>
                            <given-names>JD</given-names>
                        </name>
                        <name>
                            <surname>Pananusorn</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                    </person-group>
                    <article-title>Dopamine transporters are phosphorylated on N-terminal serines in rat striatum
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>2002</year>
                    <volume>277</volume>
                    <fpage>25178</fpage>
                    <lpage>25186</lpage>
                    <pub-id pub-id-type="pmid">11994276</pub-id>
                </citation>
            </ref>
            <ref id="B36">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Huff</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Kuhar</surname>
                            <given-names>MJ</given-names>
                        </name>
                        <name>
                            <surname>Uhl</surname>
                            <given-names>GR</given-names>
                        </name>
                    </person-group>
                    <article-title>Phorbol esters increase dopamine transporter phosphorylation and decrease transport
                        Vmax
                    </article-title>
                    <source>J Neurochem</source>
                    <year>1997</year>
                    <volume>68</volume>
                    <fpage>225</fpage>
                    <lpage>232</lpage>
                    <pub-id pub-id-type="pmid">8978729</pub-id>
                </citation>
            </ref>
            <ref id="B37">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Melikian</surname>
                            <given-names>HE</given-names>
                        </name>
                        <name>
                            <surname>Buckley</surname>
                            <given-names>KM</given-names>
                        </name>
                    </person-group>
                    <article-title>Membrane trafficking regulates the activity of the human dopamine transporter
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1999</year>
                    <volume>19</volume>
                    <fpage>7699</fpage>
                    <lpage>7710</lpage>
                    <pub-id pub-id-type="pmid">10479674</pub-id>
                </citation>
            </ref>
            <ref id="B38">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Carvelli</surname>
                            <given-names>L</given-names>
                        </name>
                        <name>
                            <surname>McDonald</surname>
                            <given-names>PW</given-names>
                        </name>
                        <name>
                            <surname>Blakely</surname>
                            <given-names>RD</given-names>
                        </name>
                        <name>
                            <surname>Defelice</surname>
                            <given-names>LJ</given-names>
                        </name>
                    </person-group>
                    <article-title>Dopamine transporters depolarize neurons by a channel mechanism</article-title>
                    <source>Proc Natl Acad Sci USA</source>
                    <year>2004</year>
                    <volume>101</volume>
                    <fpage>16046</fpage>
                    <lpage>16051</lpage>
                    <pub-id pub-id-type="pmid">15520385</pub-id>
                </citation>
            </ref>
            <ref id="B39">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ingram</surname>
                            <given-names>SL</given-names>
                        </name>
                        <name>
                            <surname>Prasad</surname>
                            <given-names>BM</given-names>
                        </name>
                        <name>
                            <surname>Amara</surname>
                            <given-names>SG</given-names>
                        </name>
                    </person-group>
                    <article-title>Dopamine transporter-mediated conductances increase excitability of midbrain dopamine
                        neurons
                    </article-title>
                    <source>Nat Neurosci</source>
                    <year>2002</year>
                    <volume>5</volume>
                    <fpage>971</fpage>
                    <lpage>978</lpage>
                    <pub-id pub-id-type="pmid">12352983</pub-id>
                </citation>
            </ref>
            <ref id="B40">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sulzer</surname>
                            <given-names>D</given-names>
                        </name>
                        <name>
                            <surname>Maidment</surname>
                            <given-names>NT</given-names>
                        </name>
                        <name>
                            <surname>Rayport</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphetamine and other weak bases act to promote reverse transport of dopamine in
                        ventral midbrain neurons
                    </article-title>
                    <source>J Neurochem</source>
                    <year>1993</year>
                    <volume>60</volume>
                    <fpage>527</fpage>
                    <lpage>535</lpage>
                    <pub-id pub-id-type="pmid">8419534</pub-id>
                </citation>
            </ref>
            <ref id="B41">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lou</surname>
                            <given-names>H</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>SK</given-names>
                        </name>
                        <name>
                            <surname>Zaitsev</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Snell</surname>
                            <given-names>CR</given-names>
                        </name>
                        <name>
                            <surname>Lu</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Loh</surname>
                            <given-names>YP</given-names>
                        </name>
                    </person-group>
                    <article-title>Sorting and activity-dependent secretion of BDNF require interaction of a specific
                        motif with the sorting receptor carboxypeptidase e
                    </article-title>
                    <source>Neuron</source>
                    <year>2005</year>
                    <volume>45</volume>
                    <fpage>245</fpage>
                    <lpage>255</lpage>
                    <pub-id pub-id-type="pmid">15664176</pub-id>
                </citation>
            </ref>
            <ref id="B42">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fricker</surname>
                            <given-names>LD</given-names>
                        </name>
                        <name>
                            <surname>Das</surname>
                            <given-names>B</given-names>
                        </name>
                        <name>
                            <surname>Angeletti</surname>
                            <given-names>RH</given-names>
                        </name>
                    </person-group>
                    <article-title>Identification of the pH-dependent membrane anchor of carboxypeptidase E (EC
                        3.4.17.10)
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>1990</year>
                    <volume>265</volume>
                    <fpage>2476</fpage>
                    <lpage>2482</lpage>
                    <pub-id pub-id-type="pmid">2303412</pub-id>
                </citation>
            </ref>
            <ref id="B43">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fricker</surname>
                            <given-names>LD</given-names>
                        </name>
                        <name>
                            <surname>Snyder</surname>
                            <given-names>SH</given-names>
                        </name>
                    </person-group>
                    <article-title>Enkephalin convertase: purification and characterization of a specific
                        enkephalin-synthesizing carboxypeptidase localized to adrenal chromaffin granules
                    </article-title>
                    <source>Proc Natl Acad Sci USA</source>
                    <year>1982</year>
                    <volume>79</volume>
                    <fpage>3886</fpage>
                    <lpage>3890</lpage>
                    <pub-id pub-id-type="pmid">6808517</pub-id>
                </citation>
            </ref>
            <ref id="B44">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hook</surname>
                            <given-names>VY</given-names>
                        </name>
                        <name>
                            <surname>Loh</surname>
                            <given-names>YP</given-names>
                        </name>
                    </person-group>
                    <article-title>Carboxypeptidase B-like converting enzyme activity in secretory granules of rat
                        pituitary
                    </article-title>
                    <source>Proc Natl Acad Sci USA</source>
                    <year>1984</year>
                    <volume>81</volume>
                    <fpage>2776</fpage>
                    <lpage>2780</lpage>
                    <pub-id pub-id-type="pmid">6326144</pub-id>
                </citation>
            </ref>
            <ref id="B45">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Dhanvantari</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Arnaoutova</surname>
                            <given-names>I</given-names>
                        </name>
                        <name>
                            <surname>Snell</surname>
                            <given-names>CR</given-names>
                        </name>
                        <name>
                            <surname>Steinbach</surname>
                            <given-names>PJ</given-names>
                        </name>
                        <name>
                            <surname>Hammond</surname>
                            <given-names>K</given-names>
                        </name>
                        <name>
                            <surname>Caputo</surname>
                            <given-names>GA</given-names>
                        </name>
                        <name>
                            <surname>London</surname>
                            <given-names>E</given-names>
                        </name>
                        <name>
                            <surname>Loh</surname>
                            <given-names>YP</given-names>
                        </name>
                    </person-group>
                    <article-title>Carboxypeptidase E, a prohormone sorting receptor, is anchored to secretory granules
                        via a C-terminal transmembrane insertion
                    </article-title>
                    <source>Biochemistry</source>
                    <year>2002</year>
                    <volume>41</volume>
                    <fpage>52</fpage>
                    <lpage>60</lpage>
                    <pub-id pub-id-type="pmid">11772002</pub-id>
                </citation>
            </ref>
            <ref id="B46">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fricker</surname>
                            <given-names>LD</given-names>
                        </name>
                    </person-group>
                    <article-title>Carboxypeptidase E</article-title>
                    <source>Annu Rev Physiol</source>
                    <year>1988</year>
                    <volume>50</volume>
                    <fpage>309</fpage>
                    <lpage>321</lpage>
                    <pub-id pub-id-type="pmid">2897826</pub-id>
                </citation>
            </ref>
            <ref id="B47">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mellman</surname>
                            <given-names>I</given-names>
                        </name>
                        <name>
                            <surname>Simons</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>
                    <article-title>The Golgi complex: in vitro veritas?</article-title>
                    <source>Cell</source>
                    <year>1992</year>
                    <volume>68</volume>
                    <fpage>829</fpage>
                    <lpage>840</lpage>
                    <pub-id pub-id-type="pmid">1547485</pub-id>
                </citation>
            </ref>
            <ref id="B48">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Lippincott-Schwartz</surname>
                            <given-names>J</given-names>
                        </name>
                        <name>
                            <surname>Roberts</surname>
                            <given-names>TH</given-names>
                        </name>
                        <name>
                            <surname>Hirschberg</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>
                    <article-title>Secretory protein trafficking and organelle dynamics in living cells</article-title>
                    <source>Annu Rev Cell Dev Biol</source>
                    <year>2000</year>
                    <volume>16</volume>
                    <fpage>557</fpage>
                    <lpage>589</lpage>
                    <pub-id pub-id-type="pmid">11031247</pub-id>
                </citation>
            </ref>
            <ref id="B49">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Trimmer</surname>
                            <given-names>JS</given-names>
                        </name>
                    </person-group>
                    <article-title>Sorting out receptor trafficking</article-title>
                    <source>Neuron</source>
                    <year>1999</year>
                    <volume>22</volume>
                    <fpage>411</fpage>
                    <lpage>412</lpage>
                    <pub-id pub-id-type="pmid">10197517</pub-id>
                </citation>
            </ref>
            <ref id="B50">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Maletic-Savatic</surname>
                            <given-names>M</given-names>
                        </name>
                        <name>
                            <surname>Malinow</surname>
                            <given-names>R</given-names>
                        </name>
                    </person-group>
                    <article-title>Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. Part I:
                        trans-Golgi network-derived organelles undergo regulated exocytosis
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1998</year>
                    <volume>18</volume>
                    <fpage>6803</fpage>
                    <lpage>6813</lpage>
                    <pub-id pub-id-type="pmid">9712651</pub-id>
                </citation>
            </ref>
            <ref id="B51">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mortensen</surname>
                            <given-names>OV</given-names>
                        </name>
                        <name>
                            <surname>Amara</surname>
                            <given-names>SG</given-names>
                        </name>
                    </person-group>
                    <article-title>Dynamic regulation of the dopamine transporter</article-title>
                    <source>Eur J Pharmacol</source>
                    <year>2003</year>
                    <volume>479</volume>
                    <fpage>159</fpage>
                    <lpage>170</lpage>
                    <pub-id pub-id-type="pmid">14612147</pub-id>
                </citation>
            </ref>
            <ref id="B52">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Foster</surname>
                            <given-names>JD</given-names>
                        </name>
                        <name>
                            <surname>Cervinski</surname>
                            <given-names>MA</given-names>
                        </name>
                        <name>
                            <surname>Gorentla</surname>
                            <given-names>BK</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                    </person-group>
                    <article-title>Regulation of the dopamine transporter by phosphorylation</article-title>
                    <source>Handb Exp Pharmacol</source>
                    <year>2006</year>
                    <fpage>197</fpage>
                    <lpage>214</lpage>
                    <pub-id pub-id-type="pmid">16722237</pub-id>
                </citation>
            </ref>
            <ref id="B53">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Doolen</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein tyrosine kinase inhibitors alter human dopamine transporter activity in
                        Xenopus oocytes
                    </article-title>
                    <source>J Pharmacol Exp Ther</source>
                    <year>2001</year>
                    <volume>296</volume>
                    <fpage>931</fpage>
                    <lpage>938</lpage>
                    <pub-id pub-id-type="pmid">11181926</pub-id>
                </citation>
            </ref>
            <ref id="B54">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pristupa</surname>
                            <given-names>ZB</given-names>
                        </name>
                        <name>
                            <surname>McConkey</surname>
                            <given-names>F</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>F</given-names>
                        </name>
                        <name>
                            <surname>Man</surname>
                            <given-names>HY</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>FJ</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>YT</given-names>
                        </name>
                        <name>
                            <surname>Niznik</surname>
                            <given-names>HB</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein kinase-mediated bidirectional trafficking and functional regulation of the
                        human dopamine transporter
                    </article-title>
                    <source>Synapse</source>
                    <year>1998</year>
                    <volume>30</volume>
                    <fpage>79</fpage>
                    <lpage>87</lpage>
                    <pub-id pub-id-type="pmid">9704884</pub-id>
                </citation>
            </ref>
            <ref id="B55">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sorkina</surname>
                            <given-names>T</given-names>
                        </name>
                        <name>
                            <surname>Hoover</surname>
                            <given-names>BR</given-names>
                        </name>
                        <name>
                            <surname>Zahniser</surname>
                            <given-names>NR</given-names>
                        </name>
                        <name>
                            <surname>Sorkin</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>
                    <article-title>Constitutive and protein kinase C-induced internalization of the dopamine transporter
                        is mediated by a clathrin-dependent mechanism
                    </article-title>
                    <source>Traffic</source>
                    <year>2005</year>
                    <volume>6</volume>
                    <fpage>157</fpage>
                    <lpage>170</lpage>
                    <pub-id pub-id-type="pmid">15634215</pub-id>
                </citation>
            </ref>
            <ref id="B56">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Granas</surname>
                            <given-names>C</given-names>
                        </name>
                        <name>
                            <surname>Ferrer</surname>
                            <given-names>J</given-names>
                        </name>
                        <name>
                            <surname>Loland</surname>
                            <given-names>CJ</given-names>
                        </name>
                        <name>
                            <surname>Javitch</surname>
                            <given-names>JA</given-names>
                        </name>
                        <name>
                            <surname>Gether</surname>
                            <given-names>U</given-names>
                        </name>
                    </person-group>
                    <article-title>N-terminal truncation of the dopamine transporter abolishes phorbol ester- and
                        substance P receptor-stimulated phosphorylation without impairing transporter internalization
                    </article-title>
                    <source>J Biol Chem</source>
                    <year>2003</year>
                    <volume>278</volume>
                    <fpage>4990</fpage>
                    <lpage>5000</lpage>
                    <pub-id pub-id-type="pmid">12464618</pub-id>
                </citation>
            </ref>
            <ref id="B57">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Blakely</surname>
                            <given-names>RD</given-names>
                        </name>
                        <name>
                            <surname>Ramamoorthy</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Schroeter</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Qian</surname>
                            <given-names>Y</given-names>
                        </name>
                        <name>
                            <surname>Apparsundaram</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Galli</surname>
                            <given-names>A</given-names>
                        </name>
                        <name>
                            <surname>DeFelice</surname>
                            <given-names>LJ</given-names>
                        </name>
                    </person-group>
                    <article-title>Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin
                        transporter proteins
                    </article-title>
                    <source>Biol Psychiatry</source>
                    <year>1998</year>
                    <volume>44</volume>
                    <fpage>169</fpage>
                    <lpage>178</lpage>
                    <pub-id pub-id-type="pmid">9693389</pub-id>
                </citation>
            </ref>
            <ref id="B58">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chang</surname>
                            <given-names>MY</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>SH</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>JH</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>KH</given-names>
                        </name>
                        <name>
                            <surname>Kim</surname>
                            <given-names>YS</given-names>
                        </name>
                        <name>
                            <surname>Son</surname>
                            <given-names>H</given-names>
                        </name>
                        <name>
                            <surname>Lee</surname>
                            <given-names>YS</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein kinase C-mediated functional regulation of dopamine transporter is not
                        achieved by direct phosphorylation of the dopamine transporter protein
                    </article-title>
                    <source>J Neurochem</source>
                    <year>2001</year>
                    <volume>77</volume>
                    <fpage>754</fpage>
                    <lpage>761</lpage>
                    <pub-id pub-id-type="pmid">11331404</pub-id>
                </citation>
            </ref>
            <ref id="B59">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Beckman</surname>
                            <given-names>ML</given-names>
                        </name>
                        <name>
                            <surname>Bernstein</surname>
                            <given-names>EM</given-names>
                        </name>
                        <name>
                            <surname>Quick</surname>
                            <given-names>MW</given-names>
                        </name>
                    </person-group>
                    <article-title>Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A
                    </article-title>
                    <source>J Neurosci</source>
                    <year>1998</year>
                    <volume>18</volume>
                    <fpage>6103</fpage>
                    <lpage>6112</lpage>
                    <pub-id pub-id-type="pmid">9698305</pub-id>
                </citation>
            </ref>
            <ref id="B60">
                <citation citation-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bauman</surname>
                            <given-names>AL</given-names>
                        </name>
                        <name>
                            <surname>Apparsundaram</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Ramamoorthy</surname>
                            <given-names>S</given-names>
                        </name>
                        <name>
                            <surname>Wadzinski</surname>
                            <given-names>BE</given-names>
                        </name>
                        <name>
                            <surname>Vaughan</surname>
                            <given-names>RA</given-names>
                        </name>
                        <name>
                            <surname>Blakely</surname>
                            <given-names>RD</given-names>
                        </name>
                    </person-group>
                    <article-title>Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated
                        complexes with protein phosphatase 2A
                    </article-title>
                    <source>J Neurosci</source>
                    <year>2000</year>
                    <volume>20</volume>
                    <fpage>7571</fpage>
                    <lpage>7578</lpage>
                    <pub-id pub-id-type="pmid">11027216</pub-id>
                </citation>
            </ref>
        </ref-list>
    </back>
</article>
